Patents Assigned to LIFE-ON TECHNOLOGY CORPORATION
  • Patent number: 12071487
    Abstract: Methods are provided for making bispecific antibodies and antibody conjugates comprising site-specifically cross-linking two or more antibodies, antibody fragments or Fc-fusion proteins. Also provided are compositions and uses for the bispecific antibodies and antibody conjugates. The bispecific antibodies may be used to treat a disease or condition. Also provided are methods for site-specifically conjugating a liposome, an mRNA or an siRNA to an antibody, and uses of the antibody-conjugated liposome, mRNA or siRNA.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: August 27, 2024
    Assignee: Life Technologies Corporation
    Inventors: Brian Agnew, Robert Aggeler
  • Patent number: 12070731
    Abstract: A method of registering a location of a dispenser array in relation to a microfluidic array is provided. One of the dispenser array and the microfluidic array can be movable in relation to the frame, and the other can be fixed relative to the frame. Their relative positions can be identified by a set of coordinates. Identification of a fiducial marker can occur in a manner permitting the fiducial reference to appear in a first position of a field of view of a first camera when the dispenser array or the microfluidic array is in an alignment position. Quantities related to a vector displacement from the alignment position to a fixed position on the microfluidic array or the dispenser array can be identified. Quantities determined can be used to guide positioning of the dispenser array relative to the microfluidic array.
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: August 27, 2024
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Colin Brenan, Jamie Cho, Javier Garcia, Robert Hess, Tanya Kanigan, Arrin Katz, Namyong Kim, John Linton, Shailesh Srivastava, Karl Yoder
  • Patent number: 12065705
    Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire. In one aspect, methods provide for determining convergence of T cell receptor and/or B cell receptor repertoires in samples prior to a treatment and predicting a subjects response to the treatment based on the measured convergence frequency. In another aspect, methods provide for an immune receptor haplotype group and predicting a subjects potential or predisposition to be protected from or vulnerable to an adverse event following a treatment.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: August 20, 2024
    Assignee: Life Technologies Corporation
    Inventor: Timothy Looney
  • Patent number: 12066399
    Abstract: Methods and apparatus relating to very large scale FET arrays for analyte measurements. ChemFET (e.g., ISFET) arrays may be fabricated using conventional CMOS processing techniques based on improved FET pixel and array designs that increase measurement sensitivity and accuracy, and at the same time facilitate significantly small pixel sizes and dense arrays. Improved array control techniques provide for rapid data acquisition from large and dense arrays. Such arrays may be employed to detect a presence and/or concentration changes of various analyte types in a wide variety of chemical and/or biological processes. In one example, chemFET arrays facilitate DNA sequencing techniques based on monitoring changes in hydrogen ion concentration (pH), changes in other analyte concentration, and/or binding events associated with chemical processes relating to DNA synthesis.
    Type: Grant
    Filed: July 14, 2023
    Date of Patent: August 20, 2024
    Assignee: Life Technologies Corporation
    Inventors: Jonathan M. Rothberg, Wolfgang Hinz, Kim L. Johnson, James Bustillo
  • Patent number: 12065643
    Abstract: Provided are methods for preparing a library of target nucleic acid sequences, as well as compositions and uses therefor. Methods comprise contacting a nucleic acid sample with a plurality of adaptors capable of amplification of one or more target nucleic acid sequences under conditions wherein the target nucleic acid(s) undergo a first amplification; digesting the resulting first amplification products; repairing the digested target amplicons; and amplifying the repaired products in a second amplification, thereby producing a library of target nucleic acid sequence. Each of the plurality of adaptor compositions comprise a handle and a targeted nucleic acid sequence and optionally one or more tag sequences. Provided methods may be carried out in a single, addition only workflow reaction, allowing for rapid production of highly multiplexed targeted libraries, optionally including unique tag sequences. Resulting library compositions are useful for a variety of applications, including sequencing applications.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: August 20, 2024
    Assignee: Life Technologies Corporation
    Inventors: Mark Andersen, Daniel Mazur, Sihong Chen, Guobin Luo, Xinzhan Peng
  • Patent number: 12065707
    Abstract: Compositions, assays, methods, diagnostic methods, kits, and diagnostic kits are disclosed for the specific and differential detection of SARS-CoV-2 and/or other viruses from samples, including veterinary samples, clinical samples, food samples, forensic sample, environmental samples (e.g., obtained from soil, garbage, sewage, air, water, food processing and manufacturing surfaces, or likewise), or biological sample obtained from a human or non-human animal.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: August 20, 2024
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Kelly Li, Ioanna Pagani, Pius Brzoska, Jisheng Li, Chunling Wang, Kathleen Hayashibara, Michael Tanner, Hong Ji, Kamini Varma, Fangqi Hu, Robert Tebbs
  • Publication number: 20240263247
    Abstract: Disclosed herein is a method including one or more of amplifying a nucleic acid sequence of interest in a sample comprising genomic DNA of a subject; amplifying a reference nucleic acid sequence in the sample; quantifying the amplified sequence of interest relative to the amplified reference sequence; and determining a copy number of the sequence of interest from the relative quantified amplified sequence of interest. The reference sequence can have at least 80% sequence identity to at least one of SEQ ID NO:1-38. Also disclosed are kits, systems and compositions that can include a first probe which specifically hybridizes to at least a portion of at least one reference sequence.
    Type: Application
    Filed: April 15, 2024
    Publication date: August 8, 2024
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: David MERRILL, Pius BRZOSKA, Zheng LI, Wendy LIN, Wing LEE, Mandi WONG
  • Patent number: 12054790
    Abstract: Methods, compositions and kits for detecting microorganisms and/or profiling microbiota such as for example through use of nucleic acid amplification and detection.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: August 6, 2024
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Ioanna Pagani, Pius Brzoska, Kelly Li, Sunali Patel, Boli Huang, Kamini Varma, Nitin Puri, Evan Diamond
  • Patent number: 12050197
    Abstract: A method for nucleic acid sequencing includes receiving a plurality of signals indicative of a parameter measured for a plurality of defined spaces, at least some of the defined spaces including one or more sample nucleic acids, the signals being responsive to a plurality of nucleotide flows introducing nucleotides to the defined spaces; determining, for at least some of the defined spaces, whether the defined space includes a sample nucleic acid; processing, for at least some of the defined spaces determined to include a sample nucleic acid, the received signals to improve a quality of the received signals; and predicting a plurality of nucleotide sequences corresponding to respective sample nucleic acids for the defined spaces based on the processed signals and the nucleotide flows.
    Type: Grant
    Filed: February 14, 2022
    Date of Patent: July 30, 2024
    Assignee: Life Technologies Corporation
    Inventors: Melville Davey, Simon Cawley, Alan Williams
  • Patent number: 12050195
    Abstract: Methods and apparatus relating to FET arrays including large FET arrays for monitoring chemical and/or biological reactions such as nucleic acid sequencing-by-synthesis reactions. Some methods provided herein relate to improving signal (and also signal to noise ratio) from released hydrogen ions during nucleic acid sequencing reactions.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: July 30, 2024
    Assignee: Life Technologies Corporation
    Inventors: Jonathan M. Rothberg, Todd Rearick
  • Patent number: 12050226
    Abstract: A buffered suspension includes a surfactant and a solid buffer particulate having a point of zero charge at least 1.2 pH units different that the pH of the buffered suspension. The buffered suspension can be prepared by mixing a stock solution with the solid buffer particulate and titrating. A method of preforming a pH sensitive process includes drawing the buffered suspension from a reservoir, filtering the solid buffer particulate from the buffered suspension, and applying the filtered solution to a sensor.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: July 30, 2024
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: James A. Ball, Jonathan Schultz
  • Patent number: 12050196
    Abstract: A method for correcting nucleotide incorporation signals for fluid potential effects or disturbances arising in nucleic acid sequencing-by-synthesis includes: disposing a plurality of template polynucleotide strands in a plurality of defined spaces disposed on a sensor array, the template polynucleotide strands having a sequencing primer and a polymerase bound therewith; exposing the template polynucleotide strands to a series of flows of nucleotide species flowed through a fluid manifold, the fluid manifold comprising passages for flowing nucleotide species and a branch passage for flowing a solution, the branch passage comprising a reference electrode and a sensing electrode; obtaining a plurality of nucleotide incorporation signals corresponding to the plurality of defined spaces, the nucleotide incorporation signals having a signal intensity related to a number of nucleotide incorporations; and correcting at least some of the plurality of nucleotide incorporation signals for fluid potential effects or dis
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: July 30, 2024
    Assignee: Life Technologies Corporation
    Inventors: Chiu Tai Andrew Wong, Todd Rearick, John Donohue
  • Patent number: 12038406
    Abstract: The described embodiments may provide a chemical detection circuit that may comprise a plurality of first output circuits at a first side and a plurality of second output circuits at a second side of the chemical detection circuit. The chemical detection circuit may further comprise a plurality of tiles of pixels each placed between respective pairs of first and second output circuits. Each tile may include four quadrants of pixels. Each quadrant may have columns with designated first columns interleaved with second columns. Each first column may be coupled to a respective first output circuit in first and second quadrants, and to a respective second output circuit in third and fourth quadrants. Each second column may be coupled to a respective second output circuit in first and second quadrants, and to a respective first output circuit in third and fourth quadrants.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: July 16, 2024
    Assignee: Life Technologies Corporation
    Inventors: Kim L. Johnson, Jeremy Jordan, Peter M Levine, Mark James Milgrew
  • Patent number: 12038405
    Abstract: Methods and apparatus relating to FET arrays for monitoring chemical and/or biological reactions such as nucleic acid sequencing-by-synthesis reactions. Some methods provided herein relate to improving signal (and also signal to noise ratio) from released hydrogen ions during nucleic acid sequencing reactions.
    Type: Grant
    Filed: May 26, 2023
    Date of Patent: July 16, 2024
    Assignee: Life Technologies Corporation
    Inventors: Mark Milgrew, Jonathan Rothberg, James Bustillo
  • Patent number: 12040048
    Abstract: The method includes compressing numbers of reads data for targeted genes of a gene expression assay performed on a test sample. The targeted genes are organized into categories. Each category represents a functional context associated with the targeted genes in that category. The numbers of reads corresponding to targeted genes each category is compressed to form a compressed value for the category. The compressed value is compared to a baseline value for the category to determine an enrichment or a loss of a signature corresponding to the functional context of the category. The method may include analyzing information from multiple assays performed on the test sample, assigning a score value to each assay result and predicting a response to immune-oncology treatment based on the assigned scores.
    Type: Grant
    Filed: February 17, 2023
    Date of Patent: July 16, 2024
    Assignee: Life Technologies Corporation
    Inventors: Fiona Hyland, Asha Kamat, Timothy Looney
  • Patent number: 12031916
    Abstract: An instrument for processing and/or measuring a biological process comprises a sample processing system and an excitation source exhibiting a spectral function of output power or intensity verses wavelength of output power or intensity. The spectral function has a minima wavelength corresponding to a local minima value of the output power or intensity; a first maxima wavelength corresponding to a first local maxima of output power or intensity, the output power or intensity at the first local maxima being greater than the output power or intensity at any wavelength less than the minima wavelength; a second maxima wavelength corresponding to a second local maxima of output power or intensity, the output power or intensity at the second local maxima being greater than the output at any wavelength greater than the minima wavelength; the minima wavelength is between the first maxima wavelength and the second maxima wavelength.
    Type: Grant
    Filed: October 7, 2022
    Date of Patent: July 9, 2024
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Mingsong Chen, Mauro Aguanno, Kuan Moon Boo, Woon Liang Terence Soh, Jacob K. Freudenthal, Jeffrey A. Marks
  • Patent number: 12012579
    Abstract: A bag assembly for use with a heat exchanger includes a flexible bag having of one or more sheets of polymeric material, the bag having a first end that bounds a first compartment and an opposing second end that bounds a second compartment, a support structure being disposed between the first compartment and the second compartment so that the first compartment is separated and isolated from the second compartment. A first inlet port, a first outlet port, and a first drain port are coupled with the flexible bag so as to communicate with the first compartment. A second inlet port, a second outlet port, and a second drain port are coupled with the flexible bag so as to communicate with the second compartment.
    Type: Grant
    Filed: October 10, 2022
    Date of Patent: June 18, 2024
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Clinton C. Staheli, Nephi D Jones, Michael E. Goodwin
  • Patent number: D1032646
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: June 25, 2024
    Assignee: Life Technologies Corporation
    Inventors: Joshua Mead, Scott Rickes, Sean Zimmerman, Alessandra Barbosa, Mio Ling, Woon Liang Soh, Kevin Mullen, Christopher Brau, Jordan Cobia, Harmon Cosme Sicat, Jr.
  • Patent number: D1037486
    Type: Grant
    Filed: March 10, 2022
    Date of Patent: July 30, 2024
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Kyle Bulloch, Xin Mathers
  • Patent number: D1039382
    Type: Grant
    Filed: November 5, 2020
    Date of Patent: August 20, 2024
    Assignee: Life Technologies Corporation
    Inventors: Paul Clark, Sandro Klein, Xin Mathers, Jeffrey Kelly, David Judd, Scott Glassman, Michael Scribner, Adrian Bird, Imran Mahmood